Is Becton, Dickinson and Company a good dividend stock?

Becton, Dickinson and Company (BDX) is a dividend-paying stock with a current dividend yield of 2.37%. Review its dividend history, payout consistency and growth to judge whether it fits your income strategy.

What is BDX's dividend yield?

The dividend yield for BDX stock is currently 2.37%.

How much does BDX pay in dividends per year?

Becton, Dickinson and Company pays an annual dividend of $3.7428 per share over the trailing twelve months.

How often does BDX pay dividends?

BDX stock pays dividends quarterly.

Is BDX's dividend growing?

Becton, Dickinson and Company's 3-year dividend CAGR is 9.77%.

BDX Stock Price, Chart, Stats & News

Becton, Dickinson and Company

Save

Overview Dividend safety Dividends Fundamentals

Becton, Dickinson and Company (BDX) is a dividend-paying stock with a current dividend yield of 2.37% as of Jul 17, 2026. It pays $3.74 per share over the trailing twelve months and distributes quarterly. Its dividend has grown at a 8.27% 5-year compound annual rate.

57.26B

Market cap

11.75x

Current P/E

11.40x

Forward P/E

2.37%

Dividend yield

$3.74

BDX dividend

Dividend safety

Strong

Dividend coverage looks healthy — BDX pays out about 28% of earnings.

See the safety analysis

BDX chart

Loading chart...

Fundamentals

Gross margin	45.76%
Operating margin	12.40%
Pretax margin	9.41%
Net margin	8.01%
Effective tax rate	14.83%
ROA	3.20%
ROE	6.93%
D/E	0.77x
Interest coverage ratio	4.81x

All financials

BDX valuation

P/E	11.75x
P/S	2.55x
P/B	1.74x
P/CF	12.98x
P/FCF	21.28x
P/OCF	12.98x
PEG	5.05x
EV multiple	7.35x

About

Health care

Sector

Medical - Instruments & Supplies

Industry

Operating globally, Becton, Dickinson and Company (BD) is a prominent enterprise focused on the development, manufacturing, and distribution of a broad spectrum of medical technology. This includes essential medical supplies, sophisticated devices, advanced laboratory equipment, and critical diagnostic products. Its extensive customer base comprises healthcare providers, clinical institutions, medical researchers, pharmaceutical firms, and the general public around the world.